A strategic investment and partnerships with Holzaphel Effective Microbes (HEM), a south-Korean company has been announced by Amway. With this collaboration, both companies will together develop personalized probiotics. Their goal is to support wellness through gut-health-related benefits. These include immunity, weight management, brain health, skin health and more.
Amway has always focused on the key strategy of nutrition innovation for its futuristic growth.
Amway has always been uniquely positioned to deliver personalized recommendations ready built vibrant wellness communities both online and offline. They have been helping people live better, healthier lives for more than 60 years, and have closely watched the evolution of, and growing trust in, personalized wellness and health. The science and innovation behind HEM’s at-home microbiome test matches Amway’s goal of accelerating the delivery of innovative wellness products to the world. It has been acknowledged by Milind Pant.
The HEM at-home microbiome test will assess the gut microbiome, allowing for a personalized recommendation that is specific to the individual needs of the customer. The product will first become available in South Korea.
HEM Co-founder and CEO Dr.Yosep Ji says, “For HEM, the partnership is an opportunity to reach customers through Amway’s trusted network of ABOs and fulfill our shared mission of helping people live healthier lives,”.
HEM is thrilled that the benefits of their science will find its way to Korean consumers and believe this partnership will fulfill their goal of helping people realize the holistic advantages of having a healthy gut microbiome.
For Amway, this is the first strategic partnership focused on providing personalized wellness solutions. The company is actively pursuing collaboration with startups in this space with an initial focus on scouting partners in South Korea, U.S. and China.